Trials / Completed
CompletedNCT04248803
Evaluation of Gluma Desensitizer in Post-treatment Sensitivity in Posterior Composite
Efficacy of Gluma Desensitizer in Controlling the Immediate Post-treatment Sensitivity in Etch-and-rinse and Self-etch Adhesive Bonded Occlusal Composite Restorations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 570 (actual)
- Sponsor
- Tamil Nadu Dr.M.G.R.Medical University · Academic / Other
- Sex
- All
- Age
- 15 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effect of Gluma desensitizer in controlling immediate post-treatment sensitivity in posterior occlusal composite restorations.
Detailed description
The primary objective of this study is to observe the effect of gluma desensitizer application in controlling the post-treatment sensitivity in posterior occlusal composite restoration in molar teeth using 2 adhesive bonding strategies. The secondary objective is to evaluate the difference in the post-treatment sensitivity on application of Gluma desensitizer either prior to or after acid etching. The different adhesive gluma desensitizer application groups are randomly divided into 6 groups, 1. Total etch control group (No gluma desensitizer application) 2. Total etch group Gluma (Kulzer GmbH, Germany) desensitizer application prior to acid etching 3. Total etch group Gluma (Kulzer GmbH, Germany) desensitizer application after acid etching 4. Self etch control group (No gluma desensitizer application) 5. Self etch group Gluma (Kulzer GmbH, Germany) desensitizer application prior to acid etching 6. Self etch group Gluma (Kulzer GmbH, Germany) desensitizer application after acid etching
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GLUMA (Kulzer GmbH, Germany) desensitizing agent | GLUMA desensitizer is used to reduce tooth sensitivity |
Timeline
- Start date
- 2020-02-06
- Primary completion
- 2025-02-20
- Completion
- 2025-02-20
- First posted
- 2020-01-30
- Last updated
- 2025-10-20
- Results posted
- 2025-10-20
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04248803. Inclusion in this directory is not an endorsement.